NCT05609487

Brief Summary

Each year, suicide is the cause of 8,580 deaths in France, it is the second leading cause of death among 15-24 year olds. People who have made a first suicide attempt are identified as being at greater risk of repeating a suicidal gesture, particularly in the first month following the gesture . At the same time, Brief Intervention Contact (BIC) is recognized as effective in reducing suicide deaths. A new brief intervention to prevent suicidal attempts has been developed in the United States by Santley \& Brown (2012) the results of its effectiveness are very encouraging. Investigators hypothesise that the implementation of a safety plan by the emergency department for suicidal patients included in the Vigilans system leads to a greater reduction in the reiteration of suicidality at 6 months compared to the usual management. Our main objective is to evaluate the effectiveness of the implementation of a safety plan by the emergency department nurse before discharge from the emergency department in reducing suicidal reiteration at six months after the suicide attempt, for suicidal patients included in the Vigilans programe, compared with the Vigilans programe alone. Our secondary objectives are

  • Reduce the reiteration of the suicidal act at 1 month
  • Encourage engagement in care at 1 month and 6 months
  • Reduce the use of emergency departments at 1 month and 6 months due to a suicidal crisis
  • Decrease suicide mortality at 6 months To study the implementation of the intervention:
  • To measure the quality of completion, and the duration of completion of the safety plan at 1 month, and 6 months.
  • Assess the acceptability of the safety plan by emergency department nurses, and then by the vigilantes.
  • Assess the acceptability of the safety plan by patient

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2,387

participants targeted

Target at P75+ for not_applicable

Timeline
8mo left

Started Sep 2023

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress80%
Sep 2023Dec 2026

First Submitted

Initial submission to the registry

November 1, 2022

Completed
7 days until next milestone

First Posted

Study publicly available on registry

November 8, 2022

Completed
11 months until next milestone

Study Start

First participant enrolled

September 25, 2023

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 15, 2026

Completed
12 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Expected
Last Updated

September 19, 2024

Status Verified

September 1, 2024

Enrollment Period

2.3 years

First QC Date

November 1, 2022

Last Update Submit

September 11, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Suicidal recurrence at 6 months

    Suicidal reiteration is characterized by non-fatal suicidal behavior, self-inflicted injury with a desire to end one's life that does not result in death (WHO).

    6 months

Secondary Outcomes (3)

  • Suicidal recurrence

    one month

  • Commitment to healthcare

    One month and 6 months

  • Death by suicide attempt

    6 months

Study Arms (2)

Control group

OTHER

Step in "control group" This stepped wedge study does not use two parallel treatment arms. The stepped wedge design allows each center to be its own "control group" and then, after implementation of the practice by the research team, to become a "intervention group". The characteristics of these two phases are detailed below. Patients included in the control phase, i.e. without intervention, will be asked not to oppose participation in the research, after having received the presentation of the study and the information notice. The data collection will be similar to the data collection during the intervention period.

Other: As usual

Protection plan group

OTHER

The intervention consists of making the protection plan in a co-constructed process with the care user. This tool is built in 6 steps, is written and takes 20 to 40 minutes to complete. These 6 steps allow to identify the first signs of a suicidal crisis and to identify different strategies to face it. They are constructed in an ascending order, with the aim of being used by the care user in an autonomous situation.

Device: Protection plan

Interventions

Patients included in the control phase, i.e. without intervention, will be asked not to oppose participation in the research, after having received the presentation of the study and the information notice. The data collection will be similar to the data collection during the intervention period.

Control group

The intervention consists of making the protection plan in a co-constructed process with the care user. This tool is built in 6 steps, is written and takes 20 to 40 minutes to complete. These 6 steps allow to identify the first signs of a suicidal crisis and to identify different strategies to face it. They are constructed in an ascending order, with the aim of being used by the care user in an autonomous situation.

Protection plan group

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years of age or older
  • Seen in an emergency department
  • Admitted in emergency department following a suicide attempt \<48h
  • whose duration of care does not exceed 24 hours
  • For whom the care project results in a return home,
  • Who agree to be included in the Vigilans system
  • Who have social security coverage
  • Fluent in French

You may not qualify if:

  • Refusal to participate in the study
  • Refusal to be accompanied by the Vigilans system
  • Hospitalisation for more than 24 hours in the immediate aftermath of the suicide attempt
  • Under protective measures.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centre Hospitalier Le Vinatier

Bron, AURA, 69678 CEDEX, France

RECRUITING

Related Publications (1)

  • Chalancon B, Haesebaert J, Vacher A, Vieux M, Simon L, Subtil F, Colin C, Poulet E, Leaune E; Investigator Associates; Expanded Scientific Nursing Committee. Implementing a nurse-led safety planning intervention in emergency departments to prevent suicide reattempts: a stepped-wedge randomized controlled trial protocol (French multicentre randomized controlled trial with a stepped-wedge design). BMC Nurs. 2025 May 19;24(1):558. doi: 10.1186/s12912-025-03121-w.

MeSH Terms

Conditions

Suicide, Attempted

Condition Hierarchy (Ancestors)

SuicideSelf-Injurious BehaviorBehavioral SymptomsBehavior

Study Officials

  • BENOIT CHALANCON, IDE

    CH LE VINATIER

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
CROSSOVER
Model Details: The study is structured in three phases: 1) translation and adaptation of the safety plan into French; 2) effectiveness study; and 3) evaluation of the implementation of the safety plan in practice
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 1, 2022

First Posted

November 8, 2022

Study Start

September 25, 2023

Primary Completion

January 15, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

September 19, 2024

Record last verified: 2024-09

Locations